Methyl aminolevulinate
- Generic Name
- Methyl aminolevulinate
- Brand Names
- Metvix, Metvixia
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11NO3
- CAS Number
- 33320-16-0
- Unique Ingredient Identifier
- 585NM85KYM
- Background
Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.
- Indication
For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).
- Associated Conditions
- Actinic Keratosis of Face and Scalp
- Associated Therapies
- -
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT03013647
- Locations
- 🇧🇷
Hospital das Clinicas, Sao Paulo, SP, Brazil
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
- Conditions
- Interventions
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2019-08-28
- Target Recruit Count
- 72
- Registration Number
- NCT02464709
- Locations
- 🇫🇮
Vaasa Central Hospital, Vaasa, Finland
🇫🇮Tampere University Hospital, Tampere, Finland
🇫🇮Päijät-Häme Central Hospital, Lahti, Finland
Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2009-03-16
- Lead Sponsor
- Universidad de Antioquia
- Target Recruit Count
- 49
- Registration Number
- NCT00629317
- Locations
- 🇨🇴
IPS Universitaria - Universidad de Antioquia, Medellin, Antioquia, Colombia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.